| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.519 | 10.440 | 4.926 | 15.945 | 30.675 | 36.618 | 40.234 | 37.450 | 21.534 | 19.767 |
| Total Income - EUR | 7.519 | 10.440 | 4.926 | 15.945 | 30.675 | 36.618 | 40.234 | 37.501 | 21.534 | 19.767 |
| Total Expenses - EUR | 10.788 | 12.013 | 5.948 | 4.304 | 9.037 | 18.374 | 11.657 | 38.381 | 23.150 | 19.770 |
| Gross Profit/Loss - EUR | -3.268 | -1.574 | -1.023 | 11.641 | 21.638 | 18.244 | 28.578 | -879 | -1.616 | -2 |
| Net Profit/Loss - EUR | -3.268 | -1.574 | -1.023 | 11.161 | 20.718 | 17.547 | 27.371 | -2.005 | -1.616 | -48 |
| Employees | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Domeniile Doctor Nelepcu Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.204 | 3.171 | 3.117 | 3.060 | 3.001 | 16.789 | 18.232 | 14.466 | 8.657 | 6.182 |
| Current Assets | 45.819 | 45.825 | 46.565 | 42.485 | 48.282 | 47.573 | 46.667 | 6.549 | 6.630 | 9.082 |
| Inventories | 26.523 | 26.200 | 24.112 | 23.670 | 23.211 | 21.943 | 21.457 | 2.198 | 24 | 0 |
| Receivables | 19.231 | 19.195 | 22.358 | 17.908 | 11.642 | 5.253 | 20.988 | 2.770 | 4.513 | 7.469 |
| Cash | 65 | 429 | 94 | 908 | 13.428 | 20.377 | 4.223 | 1.581 | 2.093 | 1.613 |
| Shareholders Funds | 2.202 | 606 | -427 | 10.742 | 31.252 | 48.206 | 57.350 | -1.962 | -4.196 | -3.600 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 46.820 | 48.390 | 50.109 | 34.803 | 20.031 | 16.156 | 7.550 | 22.978 | 19.483 | 18.864 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Domeniile Doctor Nelepcu Srl